Donoghoe Nicholas's most recent trade in Abbvie Inc was a trade of 10,061 Common Stock, $0.01 par value done at an average price of $198.6 . Disclosure was reported to the exchange on Aug. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
AbbVie | Nicholas J. Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 198.59 per share. | 05 Aug 2025 | 10,061 | 58,247 (0%) | 0% | 198.6 | 1,998,014 | Common Stock, $0.01 par value |
AbbVie | Nicholas J. Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 198.28 per share. | 05 Aug 2025 | 3,234 | 68,308 (0%) | 0% | 198.3 | 641,239 | Common Stock, $0.01 par value |
AbbVie | Nicholas J. Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.02 per share. | 28 Feb 2025 | 11,230 | 70,018 (0%) | 0% | 205.0 | 2,302,375 | Common Stock, $0.01 par value |
AbbVie | Nicholas Donoghoe J. | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 23,437 | 23,437 | - | - | Option (Right to buy) | |
AbbVie | Nicholas Donoghoe J. | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,017 | 66,920 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe J. | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,174 | 81,248 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe J. | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,634 | 76,074 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe J. | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 4,520 | 71,440 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 176.30 per share. | 20 Mar 2024 | 21,082 | 55,903 (0%) | 0% | 176.3 | 3,716,757 | Common Stock, $0.01 par value |
AbbVie | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 178.99 per share. | 28 Feb 2024 | 16,771 | 76,985 (0%) | 0% | 179.0 | 3,001,841 | Common Stock, $0.01 par value |
AbbVie | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 22,657 | 78,560 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 21,433 | 21,433 | - | - | Option (Right to buy) | |
AbbVie | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 6,042 | 84,602 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,634 | 93,756 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,520 | 89,122 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sale of securities on an exchange or to another person at price $ 154.72 per share. | 26 Dec 2023 | 2,912 | 55,903 (0%) | 0% | 154.7 | 450,545 | Common Stock, $0.01 par value |